219 related articles for article (PubMed ID: 30087163)
1. Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells.
Lau CM; Tiniakou I; Perez OA; Kirkling ME; Yap GS; Hock H; Reizis B
J Exp Med; 2018 Sep; 215(9):2265-2278. PubMed ID: 30087163
[TBL] [Abstract][Full Text] [Related]
2. NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development.
Kashiwada M; Pham NL; Pewe LL; Harty JT; Rothman PB
Blood; 2011 Jun; 117(23):6193-7. PubMed ID: 21474667
[TBL] [Abstract][Full Text] [Related]
3. Negligible Role for Deletion Mediated by cDC1 in CD8
MacNabb BW; Kline DE; Albright AR; Chen X; Leventhal DS; Savage PA; Kline J
J Immunol; 2019 May; 202(9):2628-2635. PubMed ID: 30902900
[TBL] [Abstract][Full Text] [Related]
4.
Bagadia P; O'Connor KW; Wu R; Ferris ST; Ward JP; Schreiber RD; Murphy TL; Murphy KM
J Immunol; 2021 Jul; 207(1):125-132. PubMed ID: 34135058
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
6. RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells.
Kretzer NM; Theisen DJ; Tussiwand R; Briseño CG; Grajales-Reyes GE; Wu X; Durai V; Albring J; Bagadia P; Murphy TL; Murphy KM
J Exp Med; 2016 Dec; 213(13):2871-2883. PubMed ID: 27899443
[TBL] [Abstract][Full Text] [Related]
7. cDC1 prime and are licensed by CD4
Ferris ST; Durai V; Wu R; Theisen DJ; Ward JP; Bern MD; Davidson JT; Bagadia P; Liu T; Briseño CG; Li L; Gillanders WE; Wu GF; Yokoyama WM; Murphy TL; Schreiber RD; Murphy KM
Nature; 2020 Aug; 584(7822):624-629. PubMed ID: 32788723
[TBL] [Abstract][Full Text] [Related]
8. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
[TBL] [Abstract][Full Text] [Related]
9. Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
He F; Wu Z; Liu C; Zhu Y; Zhou Y; Tian E; Rosin-Arbesfeld R; Yang D; Wang MW; Zhu D
Signal Transduct Target Ther; 2024 May; 9(1):139. PubMed ID: 38811552
[TBL] [Abstract][Full Text] [Related]
10. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
11. CD8α
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Immunology; 2020 Apr; 159(4):404-412. PubMed ID: 31909831
[TBL] [Abstract][Full Text] [Related]
12. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells.
Bar-On L; Birnberg T; Lewis KL; Edelson BT; Bruder D; Hildner K; Buer J; Murphy KM; Reizis B; Jung S
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14745-50. PubMed ID: 20679228
[TBL] [Abstract][Full Text] [Related]
13. cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1.
Ferris ST; Ohara RA; Ou F; Wu R; Huang X; Kim S; Chen J; Liu TT; Schreiber RD; Murphy TL; Murphy KM
Cancer Immunol Res; 2022 Aug; 10(8):920-931. PubMed ID: 35648641
[TBL] [Abstract][Full Text] [Related]
14. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
15. TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses.
Caronni N; Piperno GM; Simoncello F; Romano O; Vodret S; Yanagihashi Y; Dress R; Dutertre CA; Bugatti M; Bourdeley P; Del Prete A; Schioppa T; Mazza EMC; Collavin L; Zacchigna S; Ostuni R; Guermonprez P; Vermi W; Ginhoux F; Bicciato S; Nagata S; Benvenuti F
Nat Commun; 2021 Apr; 12(1):2237. PubMed ID: 33854047
[TBL] [Abstract][Full Text] [Related]
16. The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain.
Bowman-Kirigin JA; Desai R; Saunders BT; Wang AZ; Schaettler MO; Liu CJ; Livingstone AJ; Kobayashi DK; Durai V; Kretzer NM; Zipfel GJ; Leuthardt EC; Osbun JW; Chicoine MR; Kim AH; Murphy KM; Johanns TM; Zinselmeyer BH; Dunn GP
Cancer Immunol Res; 2023 Jan; 11(1):20-37. PubMed ID: 36409838
[TBL] [Abstract][Full Text] [Related]
17. Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.
Poggi M; Canault M; Favier M; Turro E; Saultier P; Ghalloussi D; Baccini V; Vidal L; Mezzapesa A; Chelghoum N; Mohand-Oumoussa B; Falaise C; Favier R; Ouwehand WH; Fiore M; Peiretti F; Morange PE; Saut N; Bernot D; Greinacher A; BioResource N; Nurden AT; Nurden P; Freson K; Trégouët DA; Raslova H; Alessi MC
Haematologica; 2017 Feb; 102(2):282-294. PubMed ID: 27663637
[TBL] [Abstract][Full Text] [Related]
18. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.
Jaiswal H; Kaushik M; Sougrat R; Gupta M; Dey A; Verma R; Ozato K; Tailor P
J Immunol; 2013 Dec; 191(12):5993-6001. PubMed ID: 24227775
[TBL] [Abstract][Full Text] [Related]
19. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
[TBL] [Abstract][Full Text] [Related]
20. A Synthetic CD8α:MyD88 Coreceptor Enhances CD8
Kaczanowska S; Joseph AM; Guo J; Tsai AK; Lasola JJ; Younger K; Zhang Y; Gonzales CV; Davila E
Cancer Res; 2017 Dec; 77(24):7049-7058. PubMed ID: 29055013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
